These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19347275)

  • 1. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
    Blander JM
    Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, cancer and chemoresistance: taking advantage of the toll-like receptor signaling pathway.
    Chen R; Alvero AB; Silasi DA; Mor G
    Am J Reprod Immunol; 2007 Feb; 57(2):93-107. PubMed ID: 17217363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
    Sarkar FH; Li Y; Wang Z; Kong D
    Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling.
    Carmody RJ; Chen YH
    Cell Mol Immunol; 2007 Feb; 4(1):31-41. PubMed ID: 17349209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-kappaB activation: from bench to bedside.
    Sethi G; Sung B; Aggarwal BB
    Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of NF-kappaB transcriptional activity.
    Vermeulen L; Vanden Berghe W; Haegeman G
    Cancer Treat Res; 2006; 130():89-102. PubMed ID: 16610704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the NF-kappaB signaling pathway: implications for human disease.
    Courtois G; Gilmore TD
    Oncogene; 2006 Oct; 25(51):6831-43. PubMed ID: 17072331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin: tool and target for intracellular NF-kappaB inhibitors.
    Wullaert A; Heyninck K; Janssens S; Beyaert R
    Trends Immunol; 2006 Nov; 27(11):533-40. PubMed ID: 16982211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.
    Fraser CC
    Int Rev Immunol; 2008; 27(5):320-50. PubMed ID: 18853342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
    Wong ET; Tergaonkar V
    Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
    Zhang Z; Rigas B
    Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of NF-kappaB signaling: 785 and counting.
    Gilmore TD; Herscovitch M
    Oncogene; 2006 Oct; 25(51):6887-99. PubMed ID: 17072334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappaB in development, prevention, and therapy of cancer.
    Van Waes C
    Clin Cancer Res; 2007 Feb; 13(4):1076-82. PubMed ID: 17317814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB and the link between inflammation and cancer.
    DiDonato JA; Mercurio F; Karin M
    Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.
    Yates LL; Górecki DC
    Acta Biochim Pol; 2006; 53(4):651-62. PubMed ID: 17068636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
    Allen CT; Ricker JL; Chen Z; Van Waes C
    Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circuitry of nuclear factor kappaB signaling.
    Hoffmann A; Baltimore D
    Immunol Rev; 2006 Apr; 210():171-86. PubMed ID: 16623771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.